Clinical trial
Efficacy of the Probiotic Lactobacillus Reuteri in Prevention of Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children and Adolescents
NCT01295918 is registered in ClinicalTrials.gov with St Marina University Hospital, Varna, Bulgaria as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of the Probiotic Lactobacillus Reuteri in Prevention of Antibiotic-associated Diarrhea and Clostridium Difficile-related Infections in Hospitalized Children and Adolescents
- Lead sponsor
- St Marina University Hospital, Varna, Bulgaria
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- February 28, 2011
- Completion date
- September 30, 2013
- Enrollment
- 100 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
antibiotic associated diarrhea, clostridium difficile infection, gastroenteritis